| 1 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1, PIK3CA, RASA1 | 7.23 |
| 2 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1, PIK3CA, RASA1 | 7.01 |
| 3 | Autosomal non-syndromic agammaglobulinemia | Enrichment | BLNK, CD79A, CD79B, PIK3R1 | 7.01 |
| 4 | Noonan syndrome and noonan-related syndrome | Enrichment | HRAS, MAP2K1, RAF1, SOS1 | 6.20 |
| 5 | Capillary malformation-arteriovenous malformation 1 | Enrichment | MAP2K1, PIK3CA, RASA1 | 5.44 |
| 6 | Noonan syndrome 3 | Enrichment | HRAS, RAF1, SOS1 | 5.44 |
| 7 | Noonan syndrome 1 | Enrichment | HRAS, MAP2K1, RAF1, SOS1 | 5.40 |
| 8 | Rasopathy | Enrichment | HRAS, MAP2K1, RAF1, SOS1 | 5.18 |
| 9 | Cowden syndrome | Enrichment | AKT1, PIK3CA, PTEN | 5.06 |
| 10 | Lung non-small cell carcinoma | Enrichment | HRAS, MAP2K1, PIK3CA | 4.77 |
| 11 | Meningioma | Enrichment | AKT1, PIK3CA, PTEN | 4.65 |
| 12 | Ectodermal dysplasia and immune deficiency | Enrichment | IKBKG, NFKBIA | 4.65 |
| 13 | Breast cancer | Enrichment | AKT1, JUN, PIK3CA, PTEN, SHC1 | 4.54 |
| 14 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | PIK3CA, PIK3R1 | 4.17 |
| 15 | Diffuse large b-cell lymphoma | Enrichment | BTK, CD79B, PTEN | 4.02 |
| 16 | Lymphoma, mucosa-associated lymphoid type | Enrichment | BCL10, MALT1 | 3.65 |
| 17 | Capillary malformations, congenital | Enrichment | PIK3CA, RASA1 | 3.65 |
| 18 | Follicular lymphoma | Enrichment | BCL10, BCL6 | 3.65 |
| 19 | Hemimegalencephaly | Enrichment | PIK3CA, PTEN | 3.65 |
| 20 | Klippel-trenaunay-weber syndrome | Enrichment | PIK3CA, RASA1 | 3.48 |
| 21 | Cowden syndrome 1 | Enrichment | PIK3CA, PTEN | 3.48 |
| 22 | Breast adenocarcinoma | Enrichment | AKT1, PIK3CA | 3.48 |
| 23 | Bladder cancer | Enrichment | HRAS, PIK3CA, PTEN | 3.45 |
| 24 | Nevus, epidermal | Enrichment | HRAS, PIK3CA | 3.33 |
| 25 | Thyroid cancer, nonmedullary, 2 | Enrichment | HRAS, PTEN | 3.33 |
| 26 | Follicular thyroid carcinoma | Enrichment | HRAS, PTEN | 3.33 |
| 27 | Severe combined immunodeficiency | Enrichment | IKBKB, MALT1, PTPRC | 3.29 |
| 28 | Melanocytic nevus syndrome, congenital | Enrichment | HRAS, RAF1 | 3.21 |
| 29 | Colorectal cancer | Enrichment | AKT1, BCL10, PIK3CA, PIK3R1 | 3.10 |
| 30 | Hereditary breast carcinoma | Enrichment | AKT1, PIK3CA, PTEN | 2.92 |
| 31 | Ovarian cancer | Enrichment | AKT1, MAP3K1, PIK3CA, PTEN | 2.86 |
| 32 | Lip and oral cavity carcinoma | Enrichment | HRAS, PIK3CA | 2.84 |
| 33 | 46,xy partial gonadal dysgenesis | Enrichment | MAP3K1, SOS1 | 2.70 |
| 34 | Rhabdomyosarcoma | Enrichment | HRAS, PTEN | 2.59 |
| 35 | Endometrial cancer | Enrichment | PIK3CA, PTEN | 2.35 |
| 36 | Macrodactyly | Enrichment | PIK3CA | 2.32 |
| 37 | Proteus syndrome | Enrichment | AKT1 | 2.32 |
| 38 | Cardiospondylocarpofacial syndrome | Enrichment | MAP3K7 | 2.32 |
| 39 | Cystic angiomatosis of bone, diffuse | Enrichment | RASA1 | 2.32 |
| 40 | Vacterl association with hydrocephalus | Enrichment | PTEN | 2.32 |
| 41 | Incontinentia pigmenti | Enrichment | IKBKG | 2.32 |
| 42 | Autoinflammatory disease, systemic, x-linked | Enrichment | IKBKG | 2.32 |
| 43 | Noonan syndrome 5 | Enrichment | RAF1 | 2.32 |
| 44 | Noonan syndrome 4 | Enrichment | SOS1 | 2.32 |
| 45 | Melorheostosis, isolated | Enrichment | MAP2K1 | 2.32 |
| 46 | Megalencephaly, autosomal dominant | Enrichment | PIK3CA | 2.32 |
| 47 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 2.32 |
| 48 | Cowden syndrome 5 | Enrichment | PIK3CA | 2.32 |
| 49 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 2.32 |
| 50 | Fetal encasement syndrome | Enrichment | CHUK | 2.32 |
| 51 | 46,xy sex reversal 6 | Enrichment | MAP3K1 | 2.32 |
| 52 | Frontometaphyseal dysplasia 2 | Enrichment | MAP3K7 | 2.32 |
| 53 | Agammaglobulinemia 3, autosomal recessive | Enrichment | CD79A | 2.32 |
| 54 | Cerebral cavernous malformations 4 | Enrichment | PIK3CA | 2.32 |
| 55 | Immunodeficiency 15b | Enrichment | IKBKB | 2.32 |
| 56 | Immunodeficiency 82 with systemic inflammation | Enrichment | SYK | 2.32 |
| 57 | Immunodeficiency 15a | Enrichment | IKBKB | 2.32 |
| 58 | Developmental and epileptic encephalopathy 91 | Enrichment | PPP3CA | 2.32 |
| 59 | Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development | Enrichment | PPP3CA | 2.32 |
| 60 | Short syndrome | Enrichment | PIK3R1 | 2.32 |
| 61 | Ectodermal dysplasia and immunodeficiency 1 | Enrichment | IKBKG | 2.32 |
| 62 | Isolated growth hormone deficiency type iii | Enrichment | BTK | 2.32 |
| 63 | Persistent polyclonal b-cell lymphocytosis | Enrichment | CARD11 | 2.32 |
| 64 | Papillary tumor of the pineal region | Enrichment | PTEN | 2.32 |
| 65 | Hemifacial myohyperplasia | Enrichment | PIK3CA | 2.32 |
| 66 | Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth | Enrichment | PIK3CA | 2.32 |
| 67 | Melorheostosis | Enrichment | MAP2K1 | 2.32 |
| 68 | Leopard syndrome 2 | Enrichment | RAF1 | 2.32 |
| 69 | Immunodeficiency 36 with lymphoproliferation | Enrichment | PIK3R1 | 2.32 |
| 70 | Autoinflammation, antibody deficiency, and immune dysregulation | Enrichment | PLCG2 | 2.32 |
| 71 | Cowden syndrome 6 | Enrichment | AKT1 | 2.32 |
| 72 | Immunodeficiency 12 | Enrichment | MALT1 | 2.32 |
| 73 | Immunodeficiency, common variable, 3 | Enrichment | CD19 | 2.32 |
| 74 | Agammaglobulinemia 7, autosomal recessive | Enrichment | PIK3R1 | 2.32 |
| 75 | Immunodeficiency 105, severe combined | Enrichment | PTPRC | 2.32 |
| 76 | Glioma susceptibility 2 | Enrichment | PTEN | 2.32 |
| 77 | Familial cold autoinflammatory syndrome 3 | Enrichment | PLCG2 | 2.32 |
| 78 | Okur-chung neurodevelopmental syndrome | Enrichment | CSNK2A1 | 2.32 |
| 79 | Bartsocas-papas syndrome 2 | Enrichment | CHUK | 2.32 |
| 80 | Autoinflammatory disease, systemic, with vasculitis | Enrichment | LYN | 2.32 |
| 81 | Cd45 deficiency | Enrichment | PTPRC | 2.32 |
| 82 | Trigonitis | Enrichment | RAF1 | 2.32 |
| 83 | Segmental progressive overgrowth syndrome with fibroadipose hyperplasia | Enrichment | PIK3CA | 2.32 |
| 84 | Sezary's disease | Enrichment | BCL10 | 2.32 |
| 85 | Intellectual developmental disorder, autosomal dominant 59 | Enrichment | CAMK2G | 2.32 |
| 86 | Hypospadias | Enrichment | PIK3CA | 2.32 |
| 87 | Colitis | Enrichment | SYK | 2.32 |
| 88 | Rare venous malformation | Enrichment | PIK3CA | 2.32 |
| 89 | Vegetative pyoderma gangrenosum | Enrichment | PTPN6 | 2.32 |
| 90 | Bullous pyoderma gangrenosum | Enrichment | PTPN6 | 2.32 |
| 91 | Gorham's disease | Enrichment | RASA1 | 2.32 |
| 92 | Diaphragmatic eventration | Enrichment | PIK3CA | 2.32 |
| 93 | Agammaglobulinemia 3 | Enrichment | CD79A | 2.32 |
| 94 | Pustular pyoderma gangrenosum | Enrichment | PTPN6 | 2.32 |
| 95 | Pik3ca-related overgrowth spectrum | Enrichment | PIK3CA | 2.32 |
| 96 | Combined immunodeficiency-hypogammaglobulinemia-skeletal anomalies syndrome due to ikbka deficiency | Enrichment | CHUK | 2.32 |
| 97 | Rare combined vascular malformation | Enrichment | PIK3CA | 2.32 |
| 98 | Cavernous lymphangioma | Enrichment | PIK3CA | 2.32 |
| 99 | Pik3ca-related overgrowth syndrome | Enrichment | PIK3CA | 2.32 |
| 100 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 2.32 |
| 101 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | Enrichment | PTEN | 2.32 |
| 102 | Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom | Enrichment | RAC1 | 2.32 |
| 103 | Classic pyoderma gangrenosum | Enrichment | PTPN6 | 2.32 |
| 104 | Hemihyperplasia-multiple lipomatosis syndrome | Enrichment | PIK3CA | 2.32 |
| 105 | Mucosa-associated lymphoma | Enrichment | BCL10 | 2.32 |
| 106 | Eccrine angiomatous hamartoma | Enrichment | PIK3CA | 2.32 |
| 107 | Macrodactyly of toe | Enrichment | PIK3CA | 2.32 |
| 108 | Malaria | Enrichment | FCGR2B, IKBKG | 2.27 |
| 109 | Prostate cancer | Enrichment | PIK3CA, PTEN | 2.07 |
| 110 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 2.02 |
| 111 | Costello syndrome | Enrichment | HRAS | 2.02 |
| 112 | Immunodeficiency 33 | Enrichment | IKBKG | 2.02 |
| 113 | Pulmonic stenosis | Enrichment | SOS1 | 2.02 |
| 114 | Isolated growth hormone deficiency, type iii, with agammaglobulinemia | Enrichment | BTK | 2.02 |
| 115 | Agammaglobulinemia 4, autosomal recessive | Enrichment | BLNK | 2.02 |
| 116 | Ectodermal dysplasia and immunodeficiency 2 | Enrichment | NFKBIA | 2.02 |
| 117 | Seizures, benign familial infantile, 2 | Enrichment | PRRT2 | 2.02 |
| 118 | Agammaglobulinemia 6, autosomal recessive | Enrichment | CD79B | 2.02 |
| 119 | Keratosis, seborrheic | Enrichment | PIK3CA | 2.02 |
| 120 | Immunodeficiency 11a | Enrichment | CARD11 | 2.02 |
| 121 | Immunodeficiency 37 | Enrichment | BCL10 | 2.02 |
| 122 | Noonan syndrome 8 | Enrichment | PIK3CA | 2.02 |
| 123 | Immunodeficiency, common variable, 12, with autoimmunity | Enrichment | NFKB1 | 2.02 |
| 124 | Myopia 28, autosomal recessive | Enrichment | DOK1 | 2.02 |
| 125 | Immunodeficiency 11b with atopic dermatitis | Enrichment | CARD11 | 2.02 |
| 126 | Intellectual developmental disorder, autosomal dominant 48 | Enrichment | RAC1 | 2.02 |
| 127 | Agammaglobulinemia, x-linked | Enrichment | BTK | 2.02 |
| 128 | Autoinflammatory disease, familial, behcet-like 3 | Enrichment | RELA | 2.02 |
| 129 | Intravascular large b-cell lymphoma | Enrichment | BCL6 | 2.02 |
| 130 | Rela fusion-positive ependymoma | Enrichment | RELA | 2.02 |
| 131 | Agammaglobulinemia 4 | Enrichment | BLNK | 2.02 |
| 132 | Agammaglobulinemia 6 | Enrichment | CD79B | 2.02 |
| 133 | Rosette-forming glioneuronal tumor | Enrichment | PIK3CA | 2.02 |
| 134 | B-cell expansion with nfkb and t-cell anergy | Enrichment | CARD11 | 2.02 |
| 135 | Immunodeficiency 104, severe combined | Enrichment | PTPRC | 2.02 |
| 136 | Glucosephosphate dehydrogenase deficiency | Enrichment | IKBKG | 2.02 |
| 137 | Common variable immunodeficiency phenotype due to cd19/cd81 deficiency | Enrichment | CD19 | 2.02 |
| 138 | Vacterl with hydrocephalus | Enrichment | PTEN | 2.02 |
| 139 | Arthritis | Enrichment | SYK | 2.02 |
| 140 | Primary mediastinal large b-cell lymphoma | Enrichment | BCL6 | 2.02 |
| 141 | Common variable immunodeficiency 12 | Enrichment | NFKB1 | 2.02 |
| 142 | Juvenile polyposis of infancy | Enrichment | PTEN | 2.02 |
| 143 | Prrt2-related disorder | Enrichment | PRRT2 | 2.02 |
| 144 | Wooly hair nevus | Enrichment | HRAS | 2.02 |
| 145 | Jacobsen syndrome | Enrichment | ETS1 | 1.84 |
| 146 | Mesothelioma, malignant | Enrichment | BCL10 | 1.84 |
| 147 | Pompe disease, infantile-onset | Enrichment | PIK3CA | 1.84 |
| 148 | Agammaglobulinemia 1, autosomal recessive | Enrichment | BTK | 1.84 |
| 149 | Nuchal bleb, familial | Enrichment | SOS1 | 1.84 |
| 150 | Langerhans cell histiocytosis | Enrichment | MAP2K1 | 1.84 |
| 151 | Glut1 deficiency syndrome 2 | Enrichment | PRRT2 | 1.84 |
| 152 | Nasopharyngeal carcinoma | Enrichment | NFKBIA | 1.84 |
| 153 | Neutrophilic dermatosis, acute febrile | Enrichment | PTPN6 | 1.84 |
| 154 | Chromosome 8p11 myeloproliferative syndrome | Enrichment | BCR | 1.84 |
| 155 | Immunodeficiency 14a with lymphoproliferation, autosomal dominant | Enrichment | PIK3R1 | 1.84 |
| 156 | Agammaglobulinemia 1 | Enrichment | BTK | 1.84 |
| 157 | Large congenital melanocytic nevus | Enrichment | HRAS | 1.84 |
| 158 | Wieacker-wolff syndrome | Enrichment | RASA1 | 1.84 |
| 159 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | BCL6 | 1.84 |
| 160 | Frontometaphyseal dysplasia | Enrichment | MAP3K7 | 1.84 |
| 161 | Immunodeficiency 14 | Enrichment | PIK3R1 | 1.84 |
| 162 | T-cell acute lymphoblastic leukemia | Enrichment | BCL10 | 1.84 |
| 163 | Laryngeal squamous cell carcinoma | Enrichment | PTEN | 1.84 |
| 164 | Spermatocytoma | Enrichment | HRAS | 1.84 |
| 165 | Testicular cancer | Enrichment | BCL10 | 1.84 |
| 166 | Keratoacanthoma | Enrichment | PIK3CA | 1.84 |
| 167 | Systemic lupus erythematosus | Enrichment | ETS1, FCGR2B | 1.83 |
| 168 | Autism spectrum disorder | Enrichment | CSNK2A1, MAP2K1, PTEN | 1.81 |
| 169 | Gastric cancer | Enrichment | PIK3CA, PTEN | 1.74 |
| 170 | Paroxysmal nonkinesigenic dyskinesia 1 | Enrichment | PRRT2 | 1.72 |
| 171 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS | 1.72 |
| 172 | Episodic kinesigenic dyskinesia 1 | Enrichment | PRRT2 | 1.72 |
| 173 | Cardiofaciocutaneous syndrome 1 | Enrichment | MAP2K1 | 1.72 |
| 174 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | PIK3CA | 1.72 |
| 175 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | BCR | 1.72 |
| 176 | Congenital generalized lipodystrophy | Enrichment | FOS | 1.72 |
| 177 | Cardiofaciocutaneous syndrome | Enrichment | MAP2K1 | 1.72 |
| 178 | Cerebrovascular disease | Enrichment | PIK3CA | 1.72 |
| 179 | Noonan syndrome with multiple lentigines | Enrichment | RAF1 | 1.72 |
| 180 | Epidermolytic nevus | Enrichment | HRAS | 1.72 |
| 181 | Familial cerebral cavernous malformations | Enrichment | PIK3CA | 1.72 |
| 182 | Familial paroxysmal nonkinesigenic dyskinesia | Enrichment | PRRT2 | 1.72 |
| 183 | Familial or sporadic hemiplegic migraine | Enrichment | PRRT2 | 1.72 |
| 184 | Glioma | Enrichment | PTEN | 1.72 |
| 185 | Gingival fibromatosis | Enrichment | SOS1 | 1.72 |
| 186 | Ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant | Enrichment | TRAF6 | 1.62 |
| 187 | Anemia, congenital, nonspherocytic hemolytic, 1 | Enrichment | IKBKG | 1.62 |
| 188 | Convulsions, familial infantile, with paroxysmal choreoathetosis | Enrichment | PRRT2 | 1.62 |
| 189 | Macrocephaly/autism syndrome | Enrichment | PTEN | 1.62 |
| 190 | Hemangioma | Enrichment | PTEN | 1.62 |
| 191 | Histiocytoid hemangioma | Enrichment | FOS | 1.62 |
| 192 | Acute megakaryocytic leukemia | Enrichment | PTEN | 1.62 |
| 193 | Self-limited infantile epilepsy | Enrichment | PRRT2 | 1.62 |
| 194 | Telangiectasia, hereditary hemorrhagic, type 1 | Enrichment | RASA1 | 1.55 |
| 195 | Hemihyperplasia, isolated | Enrichment | PIK3CA | 1.55 |
| 196 | Testicular germ cell tumor | Enrichment | BCL10 | 1.55 |
| 197 | Hemangioma, capillary infantile | Enrichment | RASA1 | 1.55 |
| 198 | Basal cell carcinoma 1 | Enrichment | RASA1 | 1.55 |
| 199 | Lung squamous cell carcinoma | Enrichment | PIK3CA | 1.55 |
| 200 | Squamous cell carcinoma, head and neck | Enrichment | PTEN | 1.48 |
| 201 | Leukemia, chronic myeloid | Enrichment | BCR | 1.48 |
| 202 | Gallbladder cancer | Enrichment | PIK3CA | 1.48 |
| 203 | Hereditary hemorrhagic telangiectasia | Enrichment | RASA1 | 1.48 |
| 204 | Pilomyxoid astrocytoma | Enrichment | RAF1 | 1.48 |
| 205 | Common variable immunodeficiency | Enrichment | NFKB1 | 1.48 |
| 206 | Overgrowth syndrome | Enrichment | PIK3R1 | 1.48 |
| 207 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | Enrichment | BCR | 1.48 |
| 208 | Lymphoma, non-hodgkin, familial | Enrichment | BCL10 | 1.42 |
| 209 | Coronary heart disease 5 | Enrichment | IKBKG | 1.37 |
| 210 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | RAC1 | 1.37 |
| 211 | Adult hepatocellular carcinoma | Enrichment | PIK3CA | 1.37 |
| 212 | Ciliary dyskinesia, primary, 3 | Enrichment | NFKB1 | 1.33 |
| 213 | Melanoma | Enrichment | PTEN | 1.33 |
| 214 | Immune deficiency disease | Enrichment | SYK | 1.29 |
| 215 | Asthma | Enrichment | CARD11 | 1.29 |
| 216 | Meningioma, familial | Enrichment | PTEN | 1.29 |
| 217 | Combined immunodeficiency | Enrichment | MALT1 | 1.29 |
| 218 | 46,xy complete gonadal dysgenesis | Enrichment | MAP3K1 | 1.29 |
| 219 | Combined t cell and b cell immunodeficiency | Enrichment | MALT1 | 1.29 |
| 220 | Uterine corpus cancer | Enrichment | PTEN | 1.29 |
| 221 | Combined t and b cell immunodeficiency | Enrichment | MALT1 | 1.29 |
| 222 | Aortic valve disease 1 | Enrichment | SOS1 | 1.22 |
| 223 | Generalized epilepsy with febrile seizures plus | Enrichment | PRRT2 | 1.19 |
| 224 | Lynch syndrome | Enrichment | PIK3CA | 1.16 |
| 225 | Gliosarcoma | Enrichment | NFKBIA | 1.13 |
| 226 | Giant cell glioblastoma | Enrichment | NFKBIA | 1.11 |
| 227 | Hepatocellular carcinoma | Enrichment | PIK3CA | 1.00 |
| 228 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | BCR | 0.98 |
| 229 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | RAF1 | 0.96 |
| 230 | Hydrops fetalis, nonimmune | Enrichment | HRAS | 0.93 |
| 231 | Differentiated thyroid carcinoma | Enrichment | HRAS | 0.89 |
| 232 | Non-immune hydrops fetalis | Enrichment | HRAS | 0.86 |
| 233 | Lung cancer | Enrichment | PIK3CA | 0.85 |
| 234 | Familial hypertrophic cardiomyopathy | Enrichment | RAF1 | 0.83 |
| 235 | Left ventricular noncompaction | Enrichment | RAF1 | 0.81 |
| 236 | Autosomal dominant non-syndromic intellectual disability | Enrichment | PPP3CA | 0.67 |
| 237 | Hypertelorism | Enrichment | PIK3CA | 0.65 |
| 238 | Familial isolated dilated cardiomyopathy | Enrichment | RAF1 | 0.65 |
| 239 | Hereditary breast ovarian cancer syndrome | Enrichment | PTEN | 0.63 |
| 240 | Undetermined early-onset epileptic encephalopathy | Enrichment | PPP3CA | 0.63 |
| 241 | Autism | Enrichment | CAMK2G | 0.53 |
| 242 | Dilated cardiomyopathy | Enrichment | RAF1 | 0.50 |
| 243 | Congenital nervous system abnormality | Enrichment | PTEN | 0.40 |
| 244 | Nervous system disease | Enrichment | PTEN | 0.40 |
| 245 | Complex neurodevelopmental disorder | Enrichment | CSNK2A1 | 0.35 |
| 246 | Inherited cancer-predisposing syndrome | Enrichment | PTEN | 0.33 |